Department of Health and Human Services · UII 009-000005317
FDA OII Systems for Inspections, Recalls, Compliance and Enforcement (SIRCE)
CIO Rating
4 - Moderately Low Risk
FY2025 Funding (PY)
$20.8M
Recompete
Low
Active Contracts
7
Recompete Signal
Recompete Probability: Low
No near-term contract end with BY funding and no sustained CIO trouble.
CIO Rating Trend
3
Oct '21
4
May '24
4-5 Low Risk3 Medium Risk1-2 High RiskNot Rated
Funding Trend
$37.0M
FY2020
PY$36.7M
FY2021
PY$34.9M
FY2022
PY$31.1M
FY2023
PY$27.6M
FY2024
PY$20.8M
FY2025
PYInternal funding (agency's own budget)Contribution (working-capital / inter-agency)CY = current year · BY = budget year (projected) · PY = prior year
Cost Pool Breakdown
Where the FY2025 spend went, broken down by category.
Internal Labor
$194K
External Labor
$0
Hardware
$0
Software
$0
Outside Services
$0
Active Contracts
| Prime | PIID | Amount | PoP Start | PoP End |
|---|---|---|---|---|
| — | 75F40122F19019 | — | — | — |
| — | HHSF22301024T | — | — | — |
| — | 75F40120F80568 | — | — | — |
| — | 75F40121F19002 | — | — | — |
| — | 75F40121F80313 | — | — | — |
| — | F231810199W | — | — | — |
| — | 75F40121F19001 | — | — | — |
Get the AI Pursuit Report for "FDA OII Systems for Inspections, Recalls, Compliance and Enforcement (SIRCE)"
Strategic interpretation, personalized fit score (NAICS + certs + past performance), incumbent analysis, and win-themes recommendations. ~6-8 page PDF, generated in 30 seconds.
$49 per report
Or included in Pro ($799/mo, 25 reports/month) and Enterprise (unlimited)